CRH Public vs James Hardie Industries
CRH and JHX side by side, both in materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRH and JHX compare
James Hardie Industries grew revenue faster over the last twelve months (24.7% versus 5.6% for CRH Public).
CRH Public keeps more of each dollar of sales as profit, with a net margin of 9.2% compared with 2.2% at James Hardie Industries.
CRH Public pays a dividend yielding 1.3%; James Hardie Industries does not pay one.
CRH Public scores higher on the StockData Score (15 against 4 for James Hardie Industries), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRH | JHX |
|---|---|---|
| Size and price | ||
| Market cap | $60.3B | – |
| Share price | $90.62 | $27.24 |
| Change, 1 year | −24.4% | 27.5% |
| Change, 5 years | 83.1% | −33.5% |
| Beta (5Y) | 1.11 | 1.33 |
| Employees | 83K | 7,500 |
| StockData Score | ||
| Total score | 15 (better) | 4 |
| Valuation score | 4 (better) | 0 |
| Growth score | 2 | 2 |
| Performance score | 4 (better) | 0 |
| Health score | 3 (better) | 2 |
| Dividend score | 2 (better) | 0 |
| Valuation | ||
| P/E | 17.0× | – |
| P/S | 1.5× | – |
| P/B | 2.4× | – |
| EV/EBITDA | 10.0× | – |
| P/FCF | 23.7× | – |
| PEG | 6.70 | – |
| FCF yield | 4.2% | – |
| Fair value | $101.39 | – |
| Margin of safety | 10.6% | – |
| Growth | ||
| Revenue growth (TTM) | 5.6% | 24.7% (better) |
| Revenue growth, 5Y average | 7.7% | 10.7% (better) |
| Net income growth (TTM) | 4.3% (better) | −75.5% |
| EPS growth (TTM) | 6.0% (better) | −80.6% |
| EPS growth, 5Y average | 31.2% (better) | −20.3% |
| Profitability | ||
| Gross margin | 36.2% (better) | 35.8% |
| Operating margin | 13.7% (better) | 9.3% |
| Net margin | 9.2% (better) | 2.2% |
| FCF margin | 6.5% (better) | 4.3% |
| Return on equity | 14.8% (better) | 2.4% |
| Return on invested capital | 10.0% (better) | 3.4% |
| Financial health | ||
| Debt / equity | 0.79 | 0.65 (better) |
| Net debt / EBITDA | 1.91 (better) | 4.24 |
| Interest coverage | 6.3× (better) | 1.9× |
| Current ratio | 1.46 | 1.59 (better) |
| Altman Z-score | 2.68 | – |
| Piotroski F-score | 6 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 1.3% | – |
| Years of dividend growth | 4 | – |
| Buyback yield | 1.6% | – |
| Shareholder yield | 2.9% | – |
| Ownership | ||
| Held by institutions | 84.7% | – |
| Held by insiders | 0.15% | 0.25% |
| Insider net buying, 12 months | $445K (better) | −$28.2M |
| Superinvestors holding | 5 | – |
| Short interest, % of float | 1.9% | – |
Go deeper
- CRH stock overview
- CRH income statement
- CRH valuation and score
- JHX stock overview
- JHX income statement
- JHX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.